Skip to main content

Day: October 3, 2025

Outcrop Silver Announces Closing of $23 Million Public Offering, Including Full Exercise of the Over-Allotment Option, Led by Investment from Jupiter Asset Management and Eric Sprott

Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) — Outcrop Silver & Gold Corporation (TSXV:OCG, OTCQX:OCGSF, DE:MRG) (“Outcrop Silver” or the “Company”) is pleased to announce that it has closed its previously announced public offering (the “Offering”) of 65,780,000 units of the Company (the “Units”) at a price of $0.35 per Unit, for aggregate gross proceeds of approximately $23,023,000, including the full exercise of the over-allotment option. The Offering was led by BMO Capital Markets, as sole bookrunner, and Research Capital Corporation, as co-lead agent, on behalf of a syndicate of agents, including SCP Resource Finance LP and Red Cloud Securities Inc. (collectively, the “Agents”). Each Unit is comprised of one common share...

Continue reading

Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

WATERTOWN, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions, today announced that three posters will be presented at the upcoming Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting, taking place November 5-9, 2025, in National Harbor, Maryland. Details for the poster presentations are as follows: Title: Sequential administration of WTX-124 and mWTX-330, IL-2 and IL-12 INDUKINE™ molecules, enhanced antitumor activity in mice bearing poorly immunogenic EMT6 tumors without systemic toxicityAbstract Number: 861Session Date and Time:...

Continue reading

California Resources Corporation Schedules Third Quarter 2025 Earnings Conference Call

LONG BEACH, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) — California Resources Corporation (NYSE: CRC) plans to release its third quarter 2025 financial results on Tuesday, November 4th after market close. The Company will hold a conference call to discuss these financial results on Wednesday, November 5th at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time). We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10202512/ffcf85d410. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. To participate in CRC’s conference call, either dial (877) 328-5505 (International callers please dial +1-412-317-5421)...

Continue reading

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

WALTHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced multiple upcoming poster presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, taking place from November 6-9, 2025 at the Gaylord National Convention Center in National Harbor, Maryland. Xilio plans to present clinical data for vilastobart, a tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4, and efarindodekin alfa (XTX301), a tumor-activated IL-12, and plans to present preclinical data highlighting the company’s masked T cell engager programs. Poster presentation details, as follows:Title: ctDNA as a Potential Surrogate Biomarker for Response...

Continue reading

BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025

SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its proprietary CAB platform for the treatment of solid tumors, today announced that clinical data for its investigational AXL-targeting antibody-drug conjugate (ADC), mecbotamab vedotin (BA3011), will be presented at the upcoming Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting to be held at National Harbor, MD from November 5-9, 2025. The presentation, titled “Median OS of 21.5 months among 44 patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma treated with mecbotamab vedotin, an AXL-targeting ADC”, will be delivered by Dr. Mihaela Druta of Moffitt Cancer...

Continue reading

Verizon Business collaborates with GE Vernova to Deliver Utilities Enhanced Grid Modernization Solutions

GE Vernova MDS™ Orbit, powered by Verizon, is now available for utilities looking to monitor, control and automate their electrical grid and other infrastructure NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) — Verizon Business today announced the GE Vernova MDS™ Orbit, an industrial wireless platform that enables utility companies to secure and protect their networks and assets, is now available on Verizon’s award-winning network. The combined offering enables GE Vernova customers a secure, reliable and flexible solution to modernize and manage their electrical grid. “As Utilities accelerate their digital transformation, they need communication platforms that are resilient, intelligent, secure and efficient”, said Mitesh Parikh, Product Line Leader, GE Vernova. “The MDS™ Orbit platform, powered by Verizon’s...

Continue reading

GoldHaven Resources Commences Maiden Diamond Drilling Program in Brazil to Test High-Priority Gold Targets

1200m Diamond Drill Program Begins at Copeçal Gold Project VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (CSE: GOH | OTCQB: GHVNF | Frankfurt: 4QS) (“GoldHaven” or the “Company”) is pleased to announce commencement of its maiden diamond drilling program at its prospective Copeçal gold Project, located within the Juruena Magmatic Arc in north-central Brazil. The upcoming drill program will test two key targets—Copeçal East and Copeçal West—identified through a combination of soil and auger drilling geochemistry, magnetic, very low frequency electromagnetic (VLF) and induced polarization (IP) surveys. These high-priority targets represent the culmination of systematic and rigorous exploration work carried out on a completely greenfields terrain.Figure 1: Copeçal Gold Project showing the...

Continue reading

Riot Announces September 2025 Production and Operations Updates

Riot Produces 445 Bitcoin in September 2025 CASTLE ROCK, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) — Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announces unaudited production and operations updates for September 2025.   Bitcoin Production and Operations Updates for September 2025              Comparison (%)Metric     September 2025 1 August 2025 1 September 2024 1 Month/Month Year/YearBitcoin Produced       445   477 412   -7% 8%Average Bitcoin Produced per Day     14.8   15.4 13.7   -4% 8%Bitcoin Held 2       19,287 3   19,309 3 10,427   -0% 85%Bitcoin Sold       465   450 –   3% N/ABitcoin Sales – Net Proceeds     $52.6 million $51.8 million –   2% N/AAverage...

Continue reading

STMicroelectronics announces timing for third quarter 2025 earnings release and conference call

STMicroelectronics announces timing for third quarter 2025 earnings release and conference call    Geneva – October 3, 2025 – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announced that it will release third quarter 2025 earnings before the opening of trading on the European Stock Exchanges on October 23, 2025. The press release will be available immediately after the release on the Company’s website at www.st.com. STMicroelectronics will conduct a conference call with analysts, investors and reporters to discuss its third quarter 2025 financial results and current business outlook on October 23, 2025 at 9:30 a.m. Central European Time (CET) / 3:30 a.m. U.S. Eastern Time (ET). A live webcast (listen-only mode) of the conference call will be accessible at...

Continue reading

Statement on the implementation of the mandatory non-competitive tender offer

PST Group AB informs that it has received a Statement on the implementation of the mandatory non-competitive tender offer from the company’s shareholder AB “HISK” (please see the attached document). More information:Tomas StukasManaging DirectorTel.: +370 618 21360AttachmentSTATEMENT ON THE IMPLEMENTATION OF THE MANDATORY (Nuorašas)

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.